2,064
Views
10
CrossRef citations to date
0
Altmetric
Articles

Two types of colistin heteroresistance in Acinetobacter baumannii isolates

, &
Pages 2114-2123 | Received 27 Jul 2020, Accepted 06 Sep 2020, Published online: 27 Sep 2020

Figures & data

Table 1. Antibiotic susceptibility profiles and genotypes of A. baumannii isolates included in this study.

Figure 1. Illustrations of methods used to measure survival rates of total and colistin-resistant populations after exposure to various colistin concentrations. (a, Experiment 1) Bacteria were cultured in MH broth containing different colistin concentrations. After incubation for 18 h at 37°C with shaking, the total surviving colonies on MH agar plates without colistin and resistant colonies on plates with 4 mg/L colistin were counted. (b, Experiment 2) Unlike experiment 1, bacterial culture exposed to colistin was diluted every hour, and plated on MH agar with or without colistin. (c, Experiment 3) The bacterial culture was transferred to fresh media at each time point, and then cultivated.

Figure 1. Illustrations of methods used to measure survival rates of total and colistin-resistant populations after exposure to various colistin concentrations. (a, Experiment 1) Bacteria were cultured in MH broth containing different colistin concentrations. After incubation for 18 h at 37°C with shaking, the total surviving colonies on MH agar plates without colistin and resistant colonies on plates with 4 mg/L colistin were counted. (b, Experiment 2) Unlike experiment 1, bacterial culture exposed to colistin was diluted every hour, and plated on MH agar with or without colistin. (c, Experiment 3) The bacterial culture was transferred to fresh media at each time point, and then cultivated.

Figure 2. The results of population analysis profiling (PAP) of Type I colistin-heteroresistant A. baumannii isolates (SCH2, SCH39, and SCH105) (A) and Type II colistin-heteroresistant A. baumannii isolates (SCH91, SCH113, and K20-B-871) (B). LOQ: limit of quantification.

Figure 2. The results of population analysis profiling (PAP) of Type I colistin-heteroresistant A. baumannii isolates (SCH2, SCH39, and SCH105) (A) and Type II colistin-heteroresistant A. baumannii isolates (SCH91, SCH113, and K20-B-871) (B). LOQ: limit of quantification.

Figure 3. The results of experiment 1. Total and colistin-resistant populations with respect to colistin concentration. The total surviving populations were identified in media without antibiotics, and colistin-resistant populations were identified in media including 4 mg/L colistin. (a) The total and colistin-resistant, surviving populations in Type I A. baumannii isolates, (b) the total and colistin-resistant, surviving populations in Type II A. baumannii isolates, (c) the rates of colistin-resistant population within the total populations in Type I A. baumannii isolates, and (d) the rates of colistin-resistant population within the total populations in Type II A. baumannii isolates.

Figure 3. The results of experiment 1. Total and colistin-resistant populations with respect to colistin concentration. The total surviving populations were identified in media without antibiotics, and colistin-resistant populations were identified in media including 4 mg/L colistin. (a) The total and colistin-resistant, surviving populations in Type I A. baumannii isolates, (b) the total and colistin-resistant, surviving populations in Type II A. baumannii isolates, (c) the rates of colistin-resistant population within the total populations in Type I A. baumannii isolates, and (d) the rates of colistin-resistant population within the total populations in Type II A. baumannii isolates.

Figure 4. The results of experiment 2. Total and colistin-resistant populations with respect to colistin concentration. (a) SCH2, a Type I A. baumannii isolates, (b) SCH91, Type II A. baumannii isolates.

Figure 4. The results of experiment 2. Total and colistin-resistant populations with respect to colistin concentration. (a) SCH2, a Type I A. baumannii isolates, (b) SCH91, Type II A. baumannii isolates.

Figure 5. The results of experiment 3. Total and colistin-resistant populations with respect to colistin concentration. (a) SCH2, a Type I A. baumannii isolates, (b) SCH91, Type II A. baumannii isolates.

Figure 5. The results of experiment 3. Total and colistin-resistant populations with respect to colistin concentration. (a) SCH2, a Type I A. baumannii isolates, (b) SCH91, Type II A. baumannii isolates.

Figure 6. (a) Colistin MIC distributions of strains in media containing 4 mg/L colistin under exposure to colistin as described in experiment 1. The grey highlighted area indicates the MIC range corresponding to colistin resistance. (b) The results of stability test for colistin resistance.

Figure 6. (a) Colistin MIC distributions of strains in media containing 4 mg/L colistin under exposure to colistin as described in experiment 1. The grey highlighted area indicates the MIC range corresponding to colistin resistance. (b) The results of stability test for colistin resistance.

Table 2. Amino acid substitutions in PmrCAB and LpxACD genes in colonies that survived in media with 4 mg/L colistin without antibiotic exposure.

Supplemental material

Supplementary_figure_2.JPG

Download ()

Supp_Figure_final.jpg

Download ()